|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 39/40 | |||
| A61K 39/21 | |||
| A61P 37/00 | |||
| C07K 16/28 |
| (11) | Patento numeris | 2037961 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07812153.0 |
| Europos patento paraiškos padavimo data | 2007-06-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-03-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-11-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/071275 |
| Data | 2007-06-14 |
| (87) | Numeris | WO 2007/147090 |
| Data | 2007-12-21 |
| (30) | Numeris | Data | Šalis |
| 813903 P | 2006-06-14 | US | |
| 871361 P | 2006-12-21 | US |
| (72) |
KOENIG, Scott, US
WILDER, Ronald, US
BONVINI, Ezio, US
JOHNSON, Leslie, S., US
PILLEMER, Stanley, US
|
| (73) |
MacroGenics, Inc.,
1500 East Gude Drive, Rockville, MD 20850-5307,
US
|
| (54) | METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS USING MONOCLONAL ANTIBODIES WITH REDUCED TOXICITY |
| METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS USING MONOCLONAL ANTIBODIES WITH REDUCED TOXICITY |